China Target Of Major Investment Plans By Germany's Merck KGaA
This article was originally published in PharmAsia News
Executive Summary
China is being targeted by German drug maker Merck KGaA for acquisitions of Chinese companies as it seeks to take advantage of a massive health-reform plan